Search Results

Active, currently enrolling    Who can join   

EXActDNA-003 / NSABP B-64: Breast Cancer Clinical Validation Study to Predict Recurrence of High-Risk Early Breast Cancer Treated With Neoadjuvant Therapy Using a Bespoke Circulating Tumor DNA Assay to Detect Molecular Residual Disease

Keywords: Oncology (Adult);Breast Cancer; ctDNA; Neoplasms by Site; Neoplasms; Breast…
Study Type: OBSERVATIONAL   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

Perioperative Versus Adjuvant Systemic Therapy in Patients With Resectable Non-Small Cell Lung Cancer - PROSPECT LUNG

Keywords: Lung Neoplasms, Respiratory Tract Neoplasms, Thoracic Neoplasms, Neoplasms by…
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Enrollment complete    Who can join   

A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab or Placebo in Patients With Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer

Keywords: Oncology (Adult); E5103; Breast Cancer;
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Enrollment complete    Who can join   

EA5163/S1709 INSIGNA : A Randomized, Phase III Study of Firstline Immunotherapy Alone or in Combination With Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) With Immunobiomarker SIGNature-Driven Analysis

Keywords: Lung Neoplasms; Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by…
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)

Keywords: Carcinoma; Lung Neoplasms; Carcinoma; Non-Small-Cell Lung; Neoplasms; Glandular…
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Enrollment complete    Who can join   

Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer (e3)

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Enrollment complete    Who can join   

A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With = 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

Randomized Placebo Controlled Trial of Bupropion For Cancer Related Fatigue

Keywords: Oncology (Adult);
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Enrollment complete    Who can join   

A Randomized Phase III Study of Ibrutinib (PCI-32765)-Based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)

Keywords: Oncology (Adult);Hematology;
Study Type: INTERVENTIONAL   |  Region: California - Northern

---